Patents
Patents for C07J 31 - Normal steroids containing one or more sulfur atoms not belonging to a hetero ring (2,027)
04/2002
04/18/2002US20020045746 Form L crystalline eplerenone having a monoclinic crystal system and an X-ray powder diffraction pattern with a peak at 8. 0+-0.2 degrees 2 theta .
04/11/2002US20020042507 Process for preparation of 9,11-epoxy steroids and intermediates useful therein
03/2002
03/28/2002US20020038021 Eplerenone crystalline form exhibiting enhanced dissolution rate
03/14/2002US20020032340 Antitumor and antirheumatic agents, high binding afinity to vitamin D receptors and weak hypercalcemic activity
03/12/2002US6355630 Estra-1,3,5(10)-triene-7α-thioethers
03/06/2002CN1080267C Preparation of intermediat of 19, 11 beta-bridge steroid
03/05/2002US6352980 Estrenes for inducting hypothalamic effects
02/2002
02/28/2002WO2002016394A1 Thioether-sulphamate steroids as steroid sulphatase inhibitors and anti-cancer compounds
02/28/2002WO2002016393A1 17-aryl-linker derivatised estrogen 3-sulphamates as inhibitors of steroid sulphatase
02/28/2002WO2002016392A1 Oestrogen-17-sulphamates as inhibitors of steroid sulphatase
02/14/2002WO2002012266A1 17.beta.-carbothioate 17.alpha.-arylcarbonyloxyloxy androstane derivative as anti-inflammatory agents
02/14/2002WO2002012265A1 6.ALPHA., 9.ALPHA.-DIFLUORO-17.ALPHA.-`(2-FURANYLCARBOXYL) OXY!-11.BETA.-HYDROXY-16.ALPHA.-METHYL-3-OXO-ANDROST-1,4,-DIENE-17-CARBOTHIOIC ACID S-FLUOROMETHYL ESTER AS AN ANTI-INFLAMMATORY AGENT
02/14/2002US20020019522 Steroids
02/14/2002US20020019378 Compounds
02/14/2002CA2634715A1 6.alpha.,9.alpha.-difluoro-17.alpha.-[(2-furanylcarboxyl)oxy}-11.beta.-hydroxy-16.alpha-methyl-3-oxo-androsta-1,4-diene-17.beta.carbothioic acids-fluoromethyl ester as an anti-inflammatory agent
02/14/2002CA2417826A1 17.beta.-carbothioate 17.alpha.-arylcarbonyloxyloxy androstane derivative as anti-inflammatory agents
02/07/2002WO2002009683A2 Aldosterone blocker therapy to prevent or treat inflammation-related disorders
02/07/2002US20020016455 Epoxidation of cyclopenta(a)phenanthrene derivatives
02/07/2002CA2416152A1 Aldosterone blocker therapy to prevent or treat inflammation-related disorders
02/06/2002EP1177206A1 3alpha-hydroxy-3beta methoxymethyl-21-heterocycle substituted steroids with anaesthetic activity
01/2002
01/31/2002WO2002008243A1 Oxidation process for preparing the intermediate 6.alpha.,9.alpha.-difluoro-11.beta.,17.alpha.-dihydroxy-16.alpha.-methyl-androst-1,4-dien-3-one 17.beta.-carboxylic acid
01/31/2002CA2406963A1 Oxidation process for preparing the intermediate 6.alpha.,9.alpha.-difluoro-11.beta.,17.alpha.-dihydroxy-16.alpha.-methyl-androst-1,4-dien-3-one 17.beta.-carboxylic acid
01/23/2002EP1173430A1 Enantiomers of mercapto lactones and processes for their synthesis
01/23/2002EP0902789B1 Androstene derivatives
01/09/2002EP1170299A2 Processes for preparation of 9,11-epoxy steroids and intermediates useful therein
01/09/2002EP1169336A1 Ent-steroids as selectively active estrogens
01/03/2002US20020002155 Glucocorticoids; antiimflammatory and immunosuppressive agents
01/02/2002EP1167381A2 Process for preparation of 7 alpha-carboxyl 9,11-epoxy steroids and Intermediates useful therein
01/02/2002EP1167380A2 11.alpha.-hydroxy-steroid-4,6-dien-3-one compounds and a process for their preparation
01/01/2002US6335441 5β-cyano-substituted steroid compounds
12/2001
12/19/2001EP1163258A1 22r-hydroxycholesta-8,14-diene derivatives for the inhibition of meiosis
12/18/2001US6331622 Processes for preparation of 9, 11-epoxy steroids and intermediates useful therein
12/05/2001EP0749437B1 Pharmaceutical uses of steroid derivatives
12/04/2001US6326503 Antitumor agents
11/2001
11/28/2001EP0906332B1 7alpha-(5-methylaminopentyl)-estratrienes, process for the preparation thereof, pharmaceutical preparations which contain said 7alpha-(5-methylaminopentyl)-estratrienes and use thereof for production of drugs
11/27/2001CA2025294C Bile acid derivatives, processes for their preparation, and use as pharmaceuticals
11/15/2001WO2001085944A2 Production of adenine nucleotide translocator (ant), novel ant ligands and screening assays therefor
11/15/2001CA2407886A1 Production of adenine nucleotide translocator (ant), novel ant ligands and screening assays therefor
10/2001
10/30/2001US6310225 Useful as intermediates for producing vitamin d derivates
10/25/2001WO2001079255A1 A process for the preparation of 7.alpha.-hydroxy 3-aminosubstituted sterols using intermediates with an unprotected 7.alpha.-hydroxy group
10/24/2001EP1148061A2 Process for preparation of 9, 11- epoxy steroids and intermediates useful therein
10/17/2001EP1144431A2 16-hydroxyestratrienes as selective estrogens
10/11/2001WO2001074840A2 17-alpha-substituted-11-beta-substituted-4-aryl and 21-substituted 19-norpregna 21-substituted 19-norpregnadienedione as antiprogestational agents
10/10/2001EP1140972A1 New 7-alpha, 17-alpha-bis-alkylated testosterone derivatives and their use in long-term therapy of androgen-dependent diseases
09/2001
09/20/2001WO2001068669A1 6-oxygenated steroidal estrogens with aromatic a and b rings
09/19/2001EP0728140B1 New steroids with radical-attracting aromatic substituents, process for the production thereof and pharmaceutical compounds containing the said substances
09/13/2001WO2001066562A1 Steroid derivatives and process for producing the same
09/11/2001US6288051 Estrogen-dependent breast cancer treatment
09/07/2001WO2001014406A8 Antiandrogen agents
09/07/2001WO2000047603A9 16-hydroxyestratrienes as selective estrogens
09/06/2001US20010020016 Formulation
08/2001
08/30/2001WO2001062722A2 Method for the preparation of fluticasone and related 17beta-carbothioic esters using a novel carbothioic acid synthesis and novel purification methods
08/28/2001US6281204 19-nor steroids having a thiocarbonated chain in position 11beta, their preparation process and the intermediates of this process, and the intermediates of this process, their use as medicaments and compositions
08/21/2001US6277838 Methods for allosteric modulation of the GABA receptor by members of the androstane and pregnane series
08/14/2001US6274572 Pregnane derivatives with no alpha-17 substitutent, their medicinal use, manufacturing method and its intermediaries and related compounds
08/02/2001WO2001055171A1 Mometasone and its preparation
08/02/2001WO2000047603A3 16-hydroxyestratrienes as selective estrogens
08/02/2001EP1144431A3 16-hydroxyestratrienes as selective estrogens
07/2001
07/26/2001WO2001052856A2 Use of dehydroepiandrosterone, its precursors and derivatives, by oral administration, as hydrating agents with direct action
07/26/2001DE10100779A1 Formulierung Formulation
07/17/2001US6262283 Stereoselective synthesis of 24-hydroxylated compounds useful for the preparation of aminosterols, vitamin D analogs, and other compounds
07/10/2001WO2001051056A1 Fulvestrant formulation
07/10/2001US6258946 Chemical intermediate for diuretic
06/2001
06/07/2001WO2001040805A1 Steroid compounds for steroid receptor binding assays
05/2001
05/16/2001EP1099706A2 Estrane sulphamate derivatives as steroid sulphatase inhibitors
03/2001
03/27/2001USRE37116 Nitrosated and nitrosylated compounds, and compositions and their use for treating respiratory disorders
03/15/2001WO2000066614A8 3α-HYDROXY-3β METHOXYMETHYL-21-HETEROCYCLE SUBSTITUTED STEROIDS WITH ANESTHETIC ACTIVITY
03/07/2001EP1081157A1 Processes for the preparation of steroid derivatives, intermediates therefor and processes for the preparation of the intermediates
03/07/2001CN1286694A Novel 19-norsteroids substd in position 11 'beta', preparation method and intermediates, application as medicines and pharmaceutical compositions contg. them
03/07/2001CN1286693A 11 'beta'-halogen-7 'alpha'-substd estratrienes, method for producing pharmaceutical preparations contg. said 11 'beta'-halogen-7 'alpha'-substd estratrienes and use of same for producing medicaments
03/06/2001US6197762 Nitrosated and nitrosylated steroids compositions, and methods for treating respiratory disorders
03/06/2001US6197761 17β-2-oxo-tetrahydrofuranyl)-carbothioic acid ester, -carboxylic acid ester and -carboxylic acid amide androstane derivatives
03/01/2001WO2001014406A1 Antiandrogen agents
02/2001
02/28/2001CN1062562C Corticosteroid 17-alkyl carbonate 21-[0]-carboxylic and carbonic esters, processes for their preparation, and pharmaceuticals containing these compounds
02/27/2001CA2081205C Steroids which inhibit angiogenesis
02/22/2001WO2000064882A3 Enantiomers of mercapto lactones and processes for their synthesis
02/06/2001US6184398 16-ene-vitamin D derivatives
01/2001
01/30/2001US6180780 Processes for preparation of 9,11-epoxy steroids and intermediates useful therein
01/23/2001US6177420 Fertility control agents; side effect reduction
01/23/2001US6177418 Epoxidized and/or hydroxylated prostane derivatives derived from a fusidium coccineum fungus metabolite isolated from metabolite mixture of fusidic acid
01/16/2001CA2140345C Anti-inflammatory compounds for ophthalmic use
01/02/2001US6169082 Salts of 8,9-dehydroestrone sulfate ester
12/2000
12/27/2000EP0716604A4 Thiol-derivatized nucleosides and oligonucleosides
12/12/2000US6159960 Steroid sulphatase inhibitors
12/05/2000CA2027627C Process for preparing 21-desoxyprednisolone 17-esters
11/2000
11/09/2000WO2000066614A1 3α-HYDROXY-3β METHOXYMETHYL-21-HETEROCYCLE SUBSTITUTED STEROIDS WITH ANESTHETIC ACTIVITY
11/09/2000CA2372342A1 3.alpha.-hydroxy-3.beta. methoxymethyl-21-heterocycle substituted steroids with anesthetic activity
11/07/2000US6143736 Methods, compositions, and compounds for allosteric modulation of the GABA receptor by members of the androstane and pregnane series
11/02/2000WO2000064882A2 Enantiomers of mercapto lactones and processes for their synthesis
11/01/2000CN1271734A Substituted 19-norsteroid, its preparation and intermediate and its medical use and composition
10/2000
10/31/2000US6140316 Estrene steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions
10/26/2000WO2000063228A1 Ent-steroids as selectively active estrogens
10/26/2000CA2371972A1 Ent-steroids as selectively active estrogens
10/25/2000CN1057770C Application of 19,11 beta-bridged sterodal compound in pharmaceutical working
10/25/2000CN1057767C Androstanes with inducing hypothalamic effects
10/19/2000DE19917930A1 Treating estrogen deficiency associated disorders, e.g. menopausal problems, osteoporosis, neoplasia or neurodegenerative disease, using new or known ent-steroids having bone-selective estrogenic activity
10/11/2000EP1042355A1 11beta-halogen-7alpha-substituted estratrienes, method for producing pharmaceutical preparations containing said 11beta-halogen-7alpha-substituted estratrienes and use of the same for producing medicaments
10/11/2000CN1057305C Estra-1,3,5(10)-triene derivatives, methods of preparing such compounds and pharmaceuticals
10/04/2000EP1039912A1 Angiostatic agents and compositions for controlling ocular hypertension
09/2000
09/28/2000WO2000056759A1 Processes for the preparation of steroid derivatives, intermediates therefor and processes for the preparation of the intermediates
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 ... 21